Related Experiment Video

Updated: Aug 22, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

Protein phosphatase 4 interacts with and down-regulates insulin receptor substrate 4 following tumor necrosis

Kathie A Mihindukulasuriya1, Guisheng Zhou, Jun Qin

  • 1Department of Immunology and Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030, USA.

The Journal of Biological Chemistry
|August 28, 2004
PubMed

Insights

Protein phosphatase 4 (PP4) targets insulin receptor substrate 4 (IRS-4) for degradation, particularly after tumor necrosis factor-alpha (TNF-alpha) stimulation. This interaction regulates IRS-4 stability and cellular signaling pathways.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Protein Biochemistry

Background:

  • Protein phosphatase 4 (PP4) is a serine/threonine phosphatase involved in critical cellular processes, including microtubule dynamics, apoptosis, and inflammatory signaling.
  • Understanding PP4's interactions is key to elucidating its diverse cellular functions.

Purpose of the Study:

  • To identify proteins that interact with PP4 using a proteomic approach.
  • To investigate the functional relationship between PP4 and its interacting partners, particularly in response to TNF-alpha stimulation.

Main Methods:

  • Proteomic analysis to identify PP4-interacting proteins.
  • Co-immunoprecipitation to confirm protein-protein interactions.
  • Pulse-chase assays to determine protein half-life.
  • Enzyme inhibition and mutant analysis to assess phosphatase activity.

Main Results:

  • Insulin receptor substrate 4 (IRS-4) was identified as a PP4-interacting protein.
  • PP4 binding and subsequent degradation of IRS-4 were enhanced by TNF-alpha stimulation.
  • PP4 mediated the TNF-alpha-induced degradation of IRS-4 in a phosphatase activity-dependent manner, significantly reducing IRS-4 half-life.

Conclusions:

  • IRS-4 is a novel substrate for PP4-mediated regulation.
  • PP4 plays a crucial role in the TNF-alpha-induced destabilization of IRS-4, impacting cellular signaling pathways.

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...